Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapidly identify CHF with POC advances.

Judith A Crook1, Fausta A Woody

  • 1Cardiovascular Services, Thunderbird Samaritan Medical Center, Glendale, AZ, USA.

Nursing Management
|January 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point-of-care: in vivo technology.

Nursing managementยท2002
See all related articles

Point-of-care testing for B-type natriuretic peptide offers a quicker and more affordable way to diagnose congestive heart failure. This approach improves diagnostic efficiency for heart failure patients.

Area of Science:

  • Cardiology
  • Biomarker Analysis
  • Diagnostic Technologies

Background:

  • Congestive heart failure (CHF) diagnosis often relies on clinical assessment and laboratory tests.
  • Timely and accurate diagnosis is crucial for effective CHF management and patient outcomes.
  • Current diagnostic methods may involve delays or higher costs.

Purpose of the Study:

  • To evaluate the utility of point-of-care B-type natriuretic peptide (BNP) testing for CHF diagnosis.
  • To assess the speed and cost-effectiveness of point-of-care BNP testing compared to traditional methods.
  • To determine if point-of-care BNP testing can expedite the diagnostic process for suspected CHF.

Main Methods:

  • A study was conducted to assess the performance of a point-of-care BNP assay.

Related Experiment Videos

  • Diagnostic accuracy and turnaround time were compared with standard laboratory methods.
  • Cost analysis was performed to evaluate economic benefits.

    • Main Results:

    • Point-of-care BNP testing demonstrated comparable accuracy to central laboratory assays.
    • The diagnostic turnaround time was significantly reduced using the point-of-care method.
    • The cost per test was found to be more economical at the point of care.

    Conclusions:

    • Point-of-care BNP testing is a viable, faster, and more cost-effective diagnostic tool for CHF.
    • Implementing point-of-care testing can improve clinical workflow and patient management for heart failure.
    • This diagnostic approach holds promise for enhancing the efficiency of CHF diagnosis in various healthcare settings.